Bank of New York Mellon’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABOS
PI
CFP
PFS
YIH
AC
Bank of New York Mellon's ABOS Position: Q2 2026 in Review
Bank of New York Mellon opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 124,377 shares worth $332K. The stake represents ﹤0.01% of the portfolio and ranks #3951 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in ABOS as recently as Q1 2025.
Bank of New York Mellon first reported a position in ABOS in Q3 2021 and has held it in 8 quarters since. 26 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.
- Bank of New York Mellon held 124,377 shares of Acumen Pharmaceuticals worth $332K as of Q2 2026.
- Acumen Pharmaceuticals was a new Bank of New York Mellon position in Q2 2026.
- Acumen Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3951 holding.
- Bank of New York Mellon first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
- 26 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.